FOXBOROUGH, Mass.--(BUSINESS WIRE)--Oct. 3, 2005--Cyberkinetics Neurotechnology Systems, Inc. (OTCBB: CYKN) (Cyberkinetics) today announced that it has named Michael J. Fritz as Director of Clinical Operations. Mr. Fritz will be responsible for all Cyberkinetics’ clinical trials to support product approval of the Company’s BrainGate(TM) Neural Interface System. He will also support the 2006 launch of Cyberkinetics’ NeuroPort(TM) Neural Monitoring System by designing clinical studies aimed at market acceptance and applications development.
